TCR2 Therapeutics Inc. (TCRR)

TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $296.70)
- $296.70 P/E (TTM): 24.21X Cap: $159.73B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $628.00)
- $628.00 P/E (TTM): 15.36X Cap: $66B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $421.67)
- $421.67 P/E (TTM): 30.19X Cap: $108.11B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $156.08)
- $156.08 P/E (TTM): 18.89X Cap: $6.43B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,420.35)
- $1,420.35 P/E (TTM): 35.67X Cap: $29.25B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $4.41)
- $4.41 Cap: $427M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $9.64)
- $9.64 Cap: $32M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022